| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races.
|
Breast
|
2007
|
1.64
|
|
2
|
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways.
|
Nat Cell Biol
|
2009
|
1.51
|
|
3
|
Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands.
|
Proc Natl Acad Sci U S A
|
2009
|
1.40
|
|
4
|
Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes.
|
Cancer Sci
|
2004
|
1.31
|
|
5
|
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival.
|
Breast Cancer Res Treat
|
2007
|
1.25
|
|
6
|
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).
|
Diagn Pathol
|
2008
|
1.17
|
|
7
|
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
|
Jpn J Clin Oncol
|
2011
|
1.07
|
|
8
|
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.
|
Breast Cancer
|
2006
|
1.05
|
|
9
|
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.
|
Cancer Sci
|
2013
|
1.03
|
|
10
|
Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.
|
J Cancer Res Clin Oncol
|
2007
|
1.02
|
|
11
|
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol.
|
Breast Cancer
|
2006
|
0.99
|
|
12
|
Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
|
Breast Cancer
|
2009
|
0.99
|
|
13
|
Significance of serum tumor markers in monitoring advanced breast cancer patients treated with systemic therapy: a prospective study.
|
Breast Cancer
|
2004
|
0.98
|
|
14
|
Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.
|
Anticancer Res
|
2006
|
0.95
|
|
15
|
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens.
|
BMC Cancer
|
2010
|
0.92
|
|
16
|
Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective.
|
Breast Cancer
|
2007
|
0.90
|
|
17
|
Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
|
Cancer Res
|
2005
|
0.89
|
|
18
|
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
|
Am J Clin Pathol
|
2007
|
0.88
|
|
19
|
Nipple adenoma found in a mastectomy specimen: report of a case with special regard to the proliferation pattern.
|
Breast Cancer
|
2007
|
0.88
|
|
20
|
Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia.
|
Mol Brain
|
2014
|
0.87
|
|
21
|
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard.
|
Am J Clin Pathol
|
2008
|
0.87
|
|
22
|
Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer.
|
Breast Cancer
|
2006
|
0.87
|
|
23
|
Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
|
Breast Cancer
|
2007
|
0.86
|
|
24
|
Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
|
Breast Cancer
|
2009
|
0.86
|
|
25
|
Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
|
Int J Oncol
|
2007
|
0.85
|
|
26
|
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.
|
Oncol Lett
|
2012
|
0.85
|
|
27
|
Benign myoepithelioma of the breast: origin and development.
|
Pathol Int
|
2009
|
0.84
|
|
28
|
Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography.
|
Magn Reson Med Sci
|
2003
|
0.84
|
|
29
|
Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
|
Breast Cancer Res Treat
|
2013
|
0.84
|
|
30
|
The C-terminal domain of the adenomatous polyposis coli (Apc) protein is involved in thyroid morphogenesis and function.
|
Med Mol Morphol
|
2011
|
0.84
|
|
31
|
Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma.
|
Breast Cancer
|
2005
|
0.83
|
|
32
|
Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
|
Int J Clin Oncol
|
2012
|
0.82
|
|
33
|
2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission.
|
Breast Cancer
|
2014
|
0.82
|
|
34
|
Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
|
BMC Cancer
|
2013
|
0.82
|
|
35
|
Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
|
Jpn J Clin Oncol
|
2006
|
0.82
|
|
36
|
ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes.
|
Biochem Biophys Res Commun
|
2012
|
0.82
|
|
37
|
Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center study.
|
Breast Cancer
|
2013
|
0.82
|
|
38
|
True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
|
Breast J
|
2009
|
0.82
|
|
39
|
Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma.
|
Pathol Int
|
2002
|
0.81
|
|
40
|
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer.
|
Exp Ther Med
|
2011
|
0.81
|
|
41
|
Predictive factors for anthracycline-based chemotherapy for human breast cancer.
|
Breast Cancer
|
2009
|
0.81
|
|
42
|
Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.
|
Horm Cancer
|
2012
|
0.81
|
|
43
|
Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).
|
Breast Cancer Res Treat
|
2007
|
0.80
|
|
44
|
99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer.
|
Surg Today
|
2006
|
0.80
|
|
45
|
Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG.
|
Breast Cancer
|
2013
|
0.80
|
|
46
|
Sudden unexpected death in patients with malignancy: a clinicopathologic study of 28 autopsy cases.
|
Pathol Res Pract
|
2006
|
0.79
|
|
47
|
[An operated case of metastasis to the small intestine from lung cancer].
|
Gan To Kagaku Ryoho
|
2011
|
0.79
|
|
48
|
Reproducible immunohistochemical criteria based on multiple raters' judgments for expression of thymidine phosphorylase in breast cancer tissue.
|
Breast Cancer Res Treat
|
2004
|
0.79
|
|
49
|
[A case report of surgical treatment for axillary lymph node metastasis from descending colon cancer].
|
Gan To Kagaku Ryoho
|
2012
|
0.79
|
|
50
|
[Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response].
|
Gan To Kagaku Ryoho
|
2007
|
0.79
|
|
51
|
[Ki67 immunohistochemical staining: the present situation of diagnostic criteria].
|
Nihon Rinsho
|
2012
|
0.79
|
|
52
|
Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society.
|
Jpn J Clin Oncol
|
2008
|
0.78
|
|
53
|
Significance of serum carcinoembryonic antigen and CA 15-3 in monitoring advanced breast cancer patients treated with systemic therapy: a large-scale retrospective study.
|
Breast Cancer
|
2003
|
0.78
|
|
54
|
Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?
|
Breast Cancer
|
2010
|
0.78
|
|
55
|
Some fine-structural findings on the thyroid gland in Apc1638T/1638T mice that express a C-terminus lacking truncated Apc.
|
Med Mol Morphol
|
2012
|
0.78
|
|
56
|
Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
|
Breast Cancer Res Treat
|
2013
|
0.77
|
|
57
|
3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.
|
Anticancer Res
|
2009
|
0.77
|
|
58
|
Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study.
|
Breast Cancer
|
2006
|
0.77
|
|
59
|
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers.
|
J Cancer Res Clin Oncol
|
2007
|
0.77
|
|
60
|
Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.
|
Breast
|
2009
|
0.77
|
|
61
|
Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis.
|
Exp Ther Med
|
2010
|
0.77
|
|
62
|
Detection of estrogen-independent growth-stimulating activity in breast cancer tissues: implication for tumor aggressiveness.
|
Cancer Microenviron
|
2013
|
0.76
|
|
63
|
Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.
|
Clin Breast Cancer
|
2011
|
0.76
|
|
64
|
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.
|
Endocr Pathol
|
2013
|
0.75
|
|
65
|
Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases.
|
Breast Cancer
|
2002
|
0.75
|
|
66
|
Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance.
|
Cancer Med
|
2012
|
0.75
|
|
67
|
[Intramucosal colorectal carcinomas treated by surgical resection].
|
Gan To Kagaku Ryoho
|
2010
|
0.75
|
|
68
|
[A case of intraductal mucinous neoplasms with the whole main pancreatic duct dilation treated via segment pancreatectomy].
|
Gan To Kagaku Ryoho
|
2011
|
0.75
|
|
69
|
[A case study of pulmonary and pancreatic metastasis from primary renal cell carcinoma more than ten years after nephrectomy].
|
Gan To Kagaku Ryoho
|
2012
|
0.75
|
|
70
|
[A case of superficial carcinoma in a diverticulum of the thoracic esophagus].
|
Gan To Kagaku Ryoho
|
2013
|
0.75
|
|
71
|
[Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].
|
Gan To Kagaku Ryoho
|
2010
|
0.75
|
|
72
|
[A case of anal metastasis from sigmoid colon cancer in a long-term survivor who had repeated local excisions].
|
Gan To Kagaku Ryoho
|
2010
|
0.75
|
|
73
|
Breast pathology slide seminar linked to poster presentations: a new idea to make case presentations in medical conferences more interactive.
|
Breast Cancer
|
2002
|
0.75
|
|
74
|
Recommendations for 'adequate evaluation of hormone receptors' a report of the task force of the Japanese Breast Cancer Society.
|
Oncol Rep
|
2010
|
0.75
|
|
75
|
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.
|
Cancer Lett
|
2008
|
0.75
|
|
76
|
Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer.
|
Breast
|
2009
|
0.75
|
|
77
|
A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).
|
Int J Clin Oncol
|
2012
|
0.75
|
|
78
|
[Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)].
|
Gan To Kagaku Ryoho
|
2007
|
0.75
|
|
79
|
Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
|
Jpn J Clin Oncol
|
2013
|
0.75
|
|
80
|
Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
|
Breast J
|
2006
|
0.75
|
|
81
|
[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial].
|
Gan To Kagaku Ryoho
|
2006
|
0.75
|
|
82
|
[A case of thrombocytopenia after microwave coagulation therapy for multiple metastatic liver tumors].
|
Gan To Kagaku Ryoho
|
2010
|
0.75
|
|
83
|
[A case of small intestinal cancer in the efferent loop of roux-en Y reconstruction after total gastrectomy and liver metastases].
|
Gan To Kagaku Ryoho
|
2011
|
0.75
|
|
84
|
Immunohistochemical study of the relationship between Ki-67 labeling index of proliferating cells of gynecomastia, histological phase and duration of disease.
|
Pathol Int
|
2006
|
0.75
|
|
85
|
Recent trends concerning sentinel lymph node biopsy for breast cancer and new methods for detection of metastasis.
|
Breast Cancer
|
2007
|
0.75
|
|
86
|
High-incidence spontaneous tumors in JF1/Ms mice: relevance of hypomorphic germline mutation and subsequent promoter methylation of Ednrb.
|
J Cancer Res Clin Oncol
|
2013
|
0.75
|